These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27484745)

  • 1. Design and characterization of a polyamine derivative inhibiting the expression of type III secretion system in Pseudomonas aeruginosa.
    Wang C; Liu X; Wang J; Zhou J; Cui Z; Zhang LH
    Sci Rep; 2016 Aug; 6():30949. PubMed ID: 27484745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence or absence of lipopolysaccharide O antigens affects type III secretion by Pseudomonas aeruginosa.
    Augustin DK; Song Y; Baek MS; Sawa Y; Singh G; Taylor B; Rubio-Mills A; Flanagan JL; Wiener-Kronish JP; Lynch SV
    J Bacteriol; 2007 Mar; 189(6):2203-9. PubMed ID: 17209027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel sensor kinase-response regulator hybrid regulates type III secretion and is required for virulence in Pseudomonas aeruginosa.
    Laskowski MA; Osborn E; Kazmierczak BI
    Mol Microbiol; 2004 Nov; 54(4):1090-103. PubMed ID: 15522089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections.
    Peña C; Cabot G; Gómez-Zorrilla S; Zamorano L; Ocampo-Sosa A; Murillas J; Almirante B; Pomar V; Aguilar M; Granados A; Calbo E; Rodríguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Oliver A;
    Clin Infect Dis; 2015 Feb; 60(4):539-48. PubMed ID: 25378459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PcrV antibody protects multi-drug resistant Pseudomonas aeruginosa induced acute lung injury.
    Wang Q; Li H; Zhou J; Zhong M; Zhu D; Feng N; Liu F; Bai C; Song Y
    Respir Physiol Neurobiol; 2014 Mar; 193():21-8. PubMed ID: 24418353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa.
    Sawa T; Ito E; Nguyen VH; Haight M
    Hum Vaccin Immunother; 2014; 10(10):2843-52. PubMed ID: 25483637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type III secretion-dependent modulation of innate immunity as one of multiple factors regulated by Pseudomonas aeruginosa RetS.
    Zolfaghar I; Evans DJ; Ronaghi R; Fleiszig SM
    Infect Immun; 2006 Jul; 74(7):3880-9. PubMed ID: 16790760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of virulence-related genes of type III secretion system of Pseudomonas aeruginosa].
    Zhuo C; Wang LX; Xiao SN; Li HY; Qiu GX; Zhong NS
    Zhonghua Shao Shang Za Zhi; 2010 Oct; 26(5):354-9. PubMed ID: 21162783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleiotropic effects of temperature-regulated 2-OH-lauroytransferase (PA0011) on Pseudomonas aeruginosa antibiotic resistance, virulence and type III secretion system.
    Wang B; Li B; Liang Y; Li J; Gao L; Chen L; Duan K; Shen L
    Microb Pathog; 2016 Feb; 91():5-17. PubMed ID: 26596709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological blocking of spermidine-mediated host-pathogen communication provides effective control against Pseudomonas aeruginosa infection.
    Wang J; Wang J; Zhang LH
    Microb Biotechnol; 2020 Jan; 13(1):87-96. PubMed ID: 29761642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection.
    Berube BJ; Murphy KR; Torhan MC; Bowlin NO; Williams JD; Bowlin TL; Moir DT; Hauser AR
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807906
    [No Abstract]   [Full Text] [Related]  

  • 12. A novel anti-anti-activator mechanism regulates expression of the Pseudomonas aeruginosa type III secretion system.
    Dasgupta N; Lykken GL; Wolfgang MC; Yahr TL
    Mol Microbiol; 2004 Jul; 53(1):297-308. PubMed ID: 15225323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PsrA is a positive transcriptional regulator of the type III secretion system in Pseudomonas aeruginosa.
    Shen DK; Filopon D; Kuhn L; Polack B; Toussaint B
    Infect Immun; 2006 Feb; 74(2):1121-9. PubMed ID: 16428760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
    Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
    PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of substrate binding specificity revealed by the crystal structures of polyamine receptors SpuD and SpuE from Pseudomonas aeruginosa.
    Wu D; Lim SC; Dong Y; Wu J; Tao F; Zhou L; Zhang LH; Song H
    J Mol Biol; 2012 Mar; 416(5):697-712. PubMed ID: 22300763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa.
    Filopon D; Mérieau A; Bernot G; Comet JP; Leberre R; Guery B; Polack B; Guespin-Michel J
    BMC Bioinformatics; 2006 May; 7():272. PubMed ID: 16734902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide analysis of host responses to the Pseudomonas aeruginosa type III secretion system yields synergistic effects.
    Ichikawa JK; English SB; Wolfgang MC; Jackson R; Butte AJ; Lory S
    Cell Microbiol; 2005 Nov; 7(11):1635-46. PubMed ID: 16207250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The salicylidene acylhydrazide INP0341 attenuates Pseudomonas aeruginosa virulence in vitro and in vivo.
    Uusitalo P; Hägglund U; Rhöös E; Scherman Norberg H; Elofsson M; Sundin C
    J Antibiot (Tokyo); 2017 Aug; 70(9):937-943. PubMed ID: 28588224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system.
    Ader F; Le Berre R; Faure K; Gosset P; Epaulard O; Toussaint B; Polack B; Nowak E; Viget NB; Kipnis E; Guery BP
    Infect Immun; 2005 Jul; 73(7):4263-71. PubMed ID: 15972518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of multidrug resistant pseudomonas aeruginosa infection and the relationship with type III secretion system in patients with diabetic foot.
    Zhang J; Chu Y; Wang P; Ji X; Li X; Wang C; Peng Y
    Int J Low Extrem Wounds; 2014 Sep; 13(3):205-10. PubMed ID: 25106442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.